MiR-429 downregulated in PAH may be beneficial for the development of pulmonary vascular remodeling, and miR-429 inhibits proliferation of PASMCs by downregulating CaSR, then results in reduced Ca2 + influx (Li et al. 2019). Here, CASR is linked to pulmonary arterial hypertension.